Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (111-120 of 496) with videos related to

Pageof 50
Sort By:
The Journal of Rheumatology|May 3, 2018
Coexisting Gout and Chondrocalcinosis on Hand RadiographFabrice Coutier, Maxime Sondag, Daniel Wendling
Joint Bone Spine|April 4, 2025
Muscle in axial spondyloarthritis: Culprit or victim?Daniel Wendling, Frank Verhoeven, Clément Prati
Joint Bone Spine|June 7, 2015
MRI aspect of intradural extramedullary lipomaClément Prati, Benoit Barbier Brion, Daniel Wendling
The Journal of Rheumatology|June 11, 2009
Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?Daniel Wendling, Vincent Di Martino, Georges Herbein
Presse Medicale (Paris, France : 1983)|April 15, 2006
[Anti-TNF alpha in the treatment of psoriatic arthritis]Pascal Claudepierre, Daniel Wendling, Jean-David Cohen
The Journal of Rheumatology|July 3, 2013
Treatment of relapsing polychondritis with tocilizumabDaniel Wendling, Marie Godfrin-Valnet, Clément Prati
Joint Bone Spine|October 4, 2015
Spondyloarthritis: Criteria, limitations, and perspectives throughout historyFernando Kemta Lekpa, Daniel Wendling, Pascal Claudepierre
Joint Bone Spine|August 5, 2008
Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapyDaniel Wendling, Jean-Pierre Cedoz, Evelyne Racadot
Clinical Rheumatology|October 2, 2008
Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patientsDaniel Wendling, Jean-Pierre Cedoz, Evelyne Racadot
The Journal of Rheumatology|March 4, 2014
Remission thresholds in spondyloarthritis: a prospective study in current practiceMarie Godfrin-Valnet, Marc Puyraveau, Daniel Wendling
Pageof 50

Showing results (111-120 of 496) with videos related to

Sort By:
Pageof 50
The Journal of Rheumatology|May 3, 2018
Coexisting Gout and Chondrocalcinosis on Hand RadiographFabrice Coutier, Maxime Sondag, Daniel Wendling
Joint Bone Spine|April 4, 2025
Muscle in axial spondyloarthritis: Culprit or victim?Daniel Wendling, Frank Verhoeven, Clément Prati
Joint Bone Spine|June 7, 2015
MRI aspect of intradural extramedullary lipomaClément Prati, Benoit Barbier Brion, Daniel Wendling
The Journal of Rheumatology|June 11, 2009
Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?Daniel Wendling, Vincent Di Martino, Georges Herbein
Presse Medicale (Paris, France : 1983)|April 15, 2006
[Anti-TNF alpha in the treatment of psoriatic arthritis]Pascal Claudepierre, Daniel Wendling, Jean-David Cohen
The Journal of Rheumatology|July 3, 2013
Treatment of relapsing polychondritis with tocilizumabDaniel Wendling, Marie Godfrin-Valnet, Clément Prati
Joint Bone Spine|October 4, 2015
Spondyloarthritis: Criteria, limitations, and perspectives throughout historyFernando Kemta Lekpa, Daniel Wendling, Pascal Claudepierre
Joint Bone Spine|August 5, 2008
Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapyDaniel Wendling, Jean-Pierre Cedoz, Evelyne Racadot
Clinical Rheumatology|October 2, 2008
Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patientsDaniel Wendling, Jean-Pierre Cedoz, Evelyne Racadot
The Journal of Rheumatology|March 4, 2014
Remission thresholds in spondyloarthritis: a prospective study in current practiceMarie Godfrin-Valnet, Marc Puyraveau, Daniel Wendling
Pageof 50